A Novel, Fully Human Anti-fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Paul PonathPina M Cardarelli

Abstract

Purpose: The ganglioside fucosyl-GM1 (FucGM1) is a tumor-associated antigen expressed in a large percentage of human small cell lung cancer (SCLC) tumors, but absent in most normal adult tissues, making it a promising target in immuno-oncology. This study was undertaken to evaluate the preclinical efficacy of BMS-986012, a novel, nonfucosylated, fully human IgG1 antibody that binds specifically to FucGM1.Experimental Design: The antitumor activity of BMS-986012 was evaluated in in vitro assays using SCLC cells and in mouse xenograft and syngeneic tumor models, with and without chemotherapeutic agents and checkpoint inhibitors.Results: BMS-986012 showed a high binding affinity for FcγRIIIa (CD16), which resulted in enhanced antibody-dependent cellular cytotoxicity (ADCC) against FucGM1-expressing tumor cell lines. BMS-986012-mediated tumor cell killing was also observed in complement-dependent cytotoxicity (CDC) and antibody-dependent cellular phagocytosis (ADCP) assays. In several mouse SCLC models, BMS-986012 demonstrated efficacy and was well tolerated. In the DMS79 xenograft model, tumor regression was achieved with BMS-986012 doses of 0.3 mg/kg and greater; antitumor activity was enhanced when BMS-986012 was combined with s...Continue Reading

References

Sep 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·F T BrezickaL Lindholm
Dec 2, 1991·International Journal of Cancer. Journal International Du Cancer·F T BrezickaL Lindholm
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R F Irie, D L Morton
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·A N HoughtonL J Old
Feb 12, 1986·Biochimica Et Biophysica Acta·P FredmanL Svennerholm
Oct 23, 1997·International Journal of Cancer. Journal International Du Cancer·S ZhangP O Livingston
Mar 8, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T BrezickaP Fredman
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Dec 23, 2000·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·T Brezicka, Z Einbeigi
Aug 28, 2002·Biochemical Society Transactions·L G PrestaY G Meng
Mar 14, 2003·Seminars in Oncology·Alan B Sandler
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lee M KrugPhilip O Livingston
Apr 20, 2006·Nature Reviews. Immunology·Paul J Carter
Sep 20, 2006·Glycobiology·Sandro SonninoAlessandro Prinetti
Mar 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Loris ZamaiMarco Vitale
Oct 5, 2007·The Oncologist·Brian E LallyMichael C Perry
Aug 30, 2008·Molecular Cancer Therapeutics·John O RichardsJohn R Desjarlais
Sep 26, 2008·The New England Journal of Medicine·Roy S HerbstScott M Lippman
Apr 30, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pina M CardarelliDavid J King
Aug 7, 2009·Cancer Immunology, Immunotherapy : CII·Pina M CardarelliDavid J King
Oct 13, 2009·The Oncologist·Jane L HurwitzDean A Fennell
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Oct 11, 2011·Nature Medicine·Kwon-Sik ParkJulien Sage
Dec 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian A GerdesPablo Umaña
May 20, 2014·The Journal of Clinical Investigation·Holbrook E KohrtRonald Levy
Apr 25, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Atsushi YonezawaHolbrook E Kohrt
Nov 2, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephanie E BuschA McGarry Houghton
Feb 22, 2017·Journal of Biomedical Science·S M ChiavennaA Vendrell
Apr 14, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kirstie L S ClearyMark S Cragg
May 24, 2017·Nature Reviews. Clinical Oncology·Joshua K SabariCharles M Rudin

❮ Previous
Next ❯

Citations

Oct 18, 2019·Cancers·Caroline Lum, Muhammad Alamgeer
Feb 20, 2020·Cancer Science·Lingyun YeCaicun Zhou
Feb 15, 2019·Frontiers in Immunology·Tao ZhangRobbert M Spaapen
Jan 20, 2021·Nature Reviews. Drug Discovery·Benjamin A H Smith, Carolyn R Bertozzi
Nov 7, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Divya ThomasPrakash Radhakrishnan
Jan 9, 2021·Rapid Communications in Mass Spectrometry : RCM·Asoka RanasingheSerhiy Hnatyshyn
Feb 6, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·John T PoirierTrudy G Oliver
Mar 20, 2021·ACS Medicinal Chemistry Letters·Prasanna SivaprakasamSanjeev Gangwar
Jul 3, 2021·International Journal of Molecular Sciences·Sophie Groux-Degroote, Philippe Delannoy
Jan 7, 2020·Current Medicinal Chemistry·Konstantin Andreev
Jan 9, 2022·Journal of Cancer Research and Clinical Oncology·Yamei ChenMing Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.